<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35688830</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>10</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>"Long COVID" results after hospitalization for SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>9581</StartPage><MedlinePgn>9581</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9581</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-13077-5</ELocationID><Abstract><AbstractText>Long-term sequelae of symptomatic infection caused by SARS-CoV-2 are largely undiscovered. We performed a prospective cohort study on consecutively hospitalized Sars-CoV-2 patients (March-May 2020) for evaluating COVID-19 outcomes at 6 and 12&#xa0;months. After hospital discharge, patients were addressed to two follow-up pathways based on respiratory support needed during hospitalization. Outcomes were assessed by telephone consultation or ambulatory visit. Among 471 patients, 80.9% received no respiratory support during hospitalization; 19.1% received non-invasive ventilation (NIV) or invasive mechanical ventilation (IMV). 58 patients died during hospitalization, therefore 413 were enrolled for follow-up. At 6&#xa0;months, among 355 patients, the 30.3% had any symptoms, 18.0% dyspnea, 6.2% neurological symptoms. Fifty-two out of 105 had major damages in interstitial computed tomography images. NIV/IMV patients had higher probability to suffer of symptoms (aOR&#x2009;=&#x2009;4.00, 95%CI:1.99-8.05), dyspnea (aOR&#x2009;=&#x2009;2.80, 95%CI:1.28-6.16), neurological symptoms (aOR&#x2009;=&#x2009;9.72, 95%CI:2.78-34.00). At 12&#xa0;months, among 344, the 25.3% suffered on any symptoms, 12.2% dyspnea, 10.1% neurological symptoms. Severe interstitial lesions were present in 37 out of 47 investigated patients. NIV/IMV patients in respect to no respiratory support, had higher probability of experiencing symptoms (aOR&#x2009;=&#x2009;3.66, 95%CI:1.73-7.74), neurological symptoms (aOR&#x2009;=&#x2009;8.96, 95%CI:3.22-24.90). COVID-19 patients showed prolonged sequelae up to 12&#xa0;months, highlighting the need of follow-up pathways for post-COVID-19 syndrome.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Rigoni</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>BIOtech Laboratories, Department of Industrial Engineering, University of Trento, Via Sommarive 9, Povo, 38123, Trento, Italy. marta.rigoni@unitn.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical, Surgical and Dental Sciences, University Statale of Milan, Milan, Italy. marta.rigoni@unitn.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Torri</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dipartimento Salute e Politiche Sociali, Provincia Autonoma di Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nollo</LastName><ForeName>Giandomenico</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>BIOtech Laboratories, Department of Industrial Engineering, University of Trento, Via Sommarive 9, Povo, 38123, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donne</LastName><ForeName>Livia Delle</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>U.O. di Medicina Interna, Ospedale di Rovereto, Azienda Sanitaria per i Servizi Provinciali di Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzardo</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>U.O. di Medicina Interna, Ospedale di Rovereto, Azienda Sanitaria per i Servizi Provinciali di Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenzi</LastName><ForeName>Lorenza</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>U.O. di Medicina Interna, Ospedale di Rovereto, Azienda Sanitaria per i Servizi Provinciali di Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falzone</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Multizonale di Radiologia Ospedale di Rovereto e Arco, Azienda Sanitaria per i Servizi Provinciali di Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozzio</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>U.O. di Medicina Interna, Ospedale di Rovereto, Azienda Sanitaria per i Servizi Provinciali di Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013689" MajorTopicYN="N">Telephone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>10</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35688830</ArticleId><ArticleId IdType="pmc">PMC9185134</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-13077-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-13077-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Coronavirus Disease (COVID-19)&#x2014;World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.</Citation></Reference><Reference><Citation>World Health Organization. Critical Preparedness, Readiness and Response Actions for COVID-19: Interim Guidance, 22 March 2020. https://apps.who.int/iris/handle/10665/331511 (2020).</Citation></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M, et al. Refining &#x201c;long-COVID&#x201d; by a prospective multimodal evaluation of patients with long-term symptoms attributed to SARS-CoV-2 infection. Infect. Dis. Ther. 2021;10:1747&#x2013;1763. doi: 10.1007/s40121-021-00484-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-021-00484-w</ArticleId><ArticleId IdType="pmc">PMC8270770</ArticleId><ArticleId IdType="pubmed">34245450</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications. JAMA. 2020;324:2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. (National Institute for Health and Care Excellence (UK), 2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Healthcare Workers. Centers for Disease Control and Prevention.https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html (2020).</Citation></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet, null. Facing up to long COVID. Lancet Lond. Engl.396, 1861 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet Lond. Engl. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325:2015&#x2013;2016. doi: 10.1001/jama.2021.5612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol. 2021 doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021 doi: 10.1007/s15010-021-01666-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nster C, et al. 6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany. PLoS ONE. 2021;16:e0255427. doi: 10.1371/journal.pone.0255427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255427</ArticleId><ArticleId IdType="pmc">PMC8341502</ArticleId><ArticleId IdType="pubmed">34351975</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19) Int. Forum Allergy Rhinol. 2021 doi: 10.1002/alr.22832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22832</ArticleId><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir. Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X, et al. Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery. J. Infect. 2021;83:381&#x2013;412. doi: 10.1016/j.jinf.2021.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.034</ArticleId><ArticleId IdType="pmc">PMC8164517</ArticleId><ArticleId IdType="pubmed">34062186</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin. Infect. Dis. 2021 doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Budhiraja S, et al. Long term health consequences of COVID-19 in hospitalized patients from North India: A follow up study of up to 12 months. Medrxiv. 2021 doi: 10.1101/2021.06.21.21258543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.21.21258543</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg. Health Eur. 2021 doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet Lond. Engl. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance. Pediatr. Med. Rodz. 2020;16:9&#x2013;26. doi: 10.15557/PiMR.2020.0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.15557/PiMR.2020.0003</ArticleId></ArticleIdList></Reference><Reference><Citation>Italian Health Ministry. General Directorate of Health Prevention. Circular letter no. 11715 of April 1st 2021. Pandemia di COVID-19&#x2014;Aggiornamento delle indicazioni sui test diagnostici e sui criteri da adottare nella determinazione delle priorit&#xe0;. Aggiornamento delle indicazioni relative alla diagnosi di laboratorio.</Citation></Reference><Reference><Citation>Duca A, Piva S, Foc&#xe0; E, Latronico N, Rizzi M. Calculated decisions: Brescia-COVID respiratory severity scale (BCRSS)/algorithm. Emerg. Med. Pract. 2020;22:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">32297727</ArticleId></ArticleIdList></Reference><Reference><Citation>Italian Health Ministry. General Directorate of Health Prevention. Circular letter no. 8248 of March 3rd 2021. Vaccinazione dei soggetti che hanno avuto un&#x2019;infezione da SARS-CoV-2.</Citation></Reference><Reference><Citation>Genecand L, et al. Diagnostic and therapeutic management of medium and long-term sequelae of SARS-CoV-2 infection. Rev. Med. Suisse. 2021;17:842&#x2013;849.</Citation><ArticleIdList><ArticleId IdType="pubmed">33908722</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestall JC, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581&#x2013;586. doi: 10.1136/thx.54.7.581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am. J. Respir. Crit. Care Med. 1998;158:1384&#x2013;1387. doi: 10.1164/ajrccm.158.5.9710086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.158.5.9710086</ArticleId><ArticleId IdType="pubmed">9817683</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, et al. Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features. Invest. Radiol. 2020;55:257&#x2013;261. doi: 10.1097/RLI.0000000000000670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLI.0000000000000670</ArticleId><ArticleId IdType="pmc">PMC7147284</ArticleId><ArticleId IdType="pubmed">32091414</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwee TC, Kwee RM. Chest CT in COVID-19: What the radiologist needs to know. Radiogr. Rev. Publ. Radiol. Soc. N. Am. Inc. 2020;40:1848&#x2013;1865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7587296</ArticleId><ArticleId IdType="pubmed">33095680</ArticleId></ArticleIdList></Reference><Reference><Citation>Infantino M, et al. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: An Italian experience. J. Med. Virol. 2020;92:1671&#x2013;1675. doi: 10.1002/jmv.25932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25932</ArticleId><ArticleId IdType="pmc">PMC7264663</ArticleId><ArticleId IdType="pubmed">32330291</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghu G, Wilson KC. COVID-19 interstitial pneumonia: Monitoring the clinical course in survivors. Lancet Respir. Med. 2020;8:839&#x2013;842. doi: 10.1016/S2213-2600(20)30349-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30349-0</ArticleId><ArticleId IdType="pmc">PMC7398671</ArticleId><ArticleId IdType="pubmed">32758440</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Testa S, et al. Implementation of tele visit healthcare services triggered by the COVID-19 emergency: The Trentino Province experience. Z. Gesundheitswissenschaften J. Public Health. 2021 doi: 10.1007/s10389-021-01609-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10389-021-01609-8</ArticleId><ArticleId IdType="pmc">PMC8203489</ArticleId><ArticleId IdType="pubmed">34150467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciarleglio FA, et al. The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access. World J. Emerg. Surg. WJES. 2021;16:37. doi: 10.1186/s13017-021-00382-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-021-00382-z</ArticleId><ArticleId IdType="pmc">PMC8276199</ArticleId><ArticleId IdType="pubmed">34256781</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigoni M, Torri E, Nollo G, Delle Donne L, Cozzio S. NEWS2 is a valuable tool for appropriate clinical management of COVID-19 patients. Eur. J. Intern. Med. 2021;85:118&#x2013;120. doi: 10.1016/j.ejim.2020.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2020.11.020</ArticleId><ArticleId IdType="pmc">PMC7751376</ArticleId><ArticleId IdType="pubmed">33358535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, et al. Symptoms, complications and management of long COVID: a review. J. R. Soc. Med. 2021 doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesuthasan A, Massey F, Manji H, Zandi MS, Wiethoff S. Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19. J. Neurol. Sci. 2021;428:117608. doi: 10.1016/j.jns.2021.117608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117608</ArticleId><ArticleId IdType="pmc">PMC8332920</ArticleId><ArticleId IdType="pubmed">34391037</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratta JM, Tompary A, Siano S, Floris-Moore M, Weber DJ. Postacute sequelae of COVID-19 infection and development of a physiatry-led recovery clinic. Am. J. Phys. Med. Rehabil. 2021;100:633&#x2013;634. doi: 10.1097/PHM.0000000000001778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001778</ArticleId><ArticleId IdType="pmc">PMC8186261</ArticleId><ArticleId IdType="pubmed">34131092</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;S0953&#x2013;6205(21):00208&#x2013;209. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco J-R, et al. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2021;27:892&#x2013;896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7920814</ArticleId><ArticleId IdType="pubmed">33662544</ArticleId></ArticleIdList></Reference><Reference><Citation>Sideris GA, et al. Imaging in the COVID-19 era: Lessons learned during a pandemic. World J. Radiol. 2021;13:192&#x2013;222. doi: 10.4329/wjr.v13.i6.192.</Citation><ArticleIdList><ArticleId IdType="doi">10.4329/wjr.v13.i6.192</ArticleId><ArticleId IdType="pmc">PMC8245753</ArticleId><ArticleId IdType="pubmed">34249239</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, et al. Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors. Sci. Rep. 2021;11:13854. doi: 10.1038/s41598-021-93191-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93191-y</ArticleId><ArticleId IdType="pmc">PMC8257634</ArticleId><ArticleId IdType="pubmed">34226597</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing ED, et al. SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity. medrxiv. 2021 doi: 10.1101/2021.04.27.21256207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.27.21256207</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao K, et al. Antibodies can last for more than 1 year after SARS-CoV-2 infection: A follow-up study from survivors of COVID-19. Front. Med. 2021;8:684864. doi: 10.3389/fmed.2021.684864.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.684864</ArticleId><ArticleId IdType="pmc">PMC8322582</ArticleId><ArticleId IdType="pubmed">34336891</ArticleId></ArticleIdList></Reference><Reference><Citation>Haveri A, et al. Persistence of neutralizing antibodies a year after SARS-CoV-2 infection. medrxiv. 2021 doi: 10.1101/2021.07.13.21260426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.13.21260426</ArticleId><ArticleId IdType="pmc">PMC8646652</ArticleId><ArticleId IdType="pubmed">34580856</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitale J, et al. Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy. JAMA Intern. Med. 2021 doi: 10.1001/jamainternmed.2021.2959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.2959</ArticleId><ArticleId IdType="pmc">PMC8164145</ArticleId><ArticleId IdType="pubmed">34048531</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Vaccine Tracker | European Centre for Disease Prevention and Control. https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab.</Citation></Reference><Reference><Citation>Pilati F, Tronconi R, Nollo G, Heragu SS, Zerzer F. Digital twin of COVID-19 mass vaccination centers. Sustainability. 2021;13:7396. doi: 10.3390/su13137396.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/su13137396</ArticleId></ArticleIdList></Reference><Reference><Citation>Nollo, G., Pilati, F, F., Tronconi, R. &amp; Rigoni, M. Industry 4.0 at the service of public health against the COVID-19 pandemic. Disaster Med. Public Health Prep.In press,.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8529351</ArticleId><ArticleId IdType="pubmed">34498556</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, et al. The conundrum of &#x2018;long-COVID-19&#x2019;: A narrative review. Int. J. Gen. Med. 2021;14:2491&#x2013;2506. doi: 10.2147/IJGM.S316708.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S316708</ArticleId><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS ONE. 2021;16:e0254523. doi: 10.1371/journal.pone.0254523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan, S. et al. In the Wake of the Pandemic: Preparing for Long COVID. (European Observatory on Health Systems and Policies, 2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera JE, et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PM R. 2021 doi: 10.1002/pmrj.12684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12684</ArticleId><ArticleId IdType="pmc">PMC8441628</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann HJ, et al. Using GRADE in situations of emergencies and urgencies: certainty in evidence and recommendations matters during the COVID-19 pandemic, now more than ever and no matter what. J. Clin. Epidemiol. 2020;127:202&#x2013;207. doi: 10.1016/j.jclinepi.2020.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.05.030</ArticleId><ArticleId IdType="pmc">PMC7274969</ArticleId><ArticleId IdType="pubmed">32512187</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglietta A, et al. Health technology assessment applied to emergency preparedness: a new perspective. Int. J. Technol. Assess. Health Care. 2021;37:e77. doi: 10.1017/S0266462321000465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462321000465</ArticleId><ArticleId IdType="pubmed">34269171</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossi A, et al. Hospital contextual factors affecting the implementation of health technologies: A systematic review. BMC Health Serv. Res. 2021;21:407. doi: 10.1186/s12913-021-06423-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-021-06423-2</ArticleId><ArticleId IdType="pmc">PMC8088675</ArticleId><ArticleId IdType="pubmed">33933068</ArticleId></ArticleIdList></Reference><Reference><Citation>Torri E, Nollo G. Public health decision-making in the real world: Four points to reshape it after COVID-19. Disaster Med. Public Health Prep. 2020 doi: 10.1017/dmp.2020.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/dmp.2020.108</ArticleId><ArticleId IdType="pmc">PMC7211795</ArticleId><ArticleId IdType="pubmed">32314952</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>